Transcontinental Inc
F:53L
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Transcontinental Inc
F:53L
|
CA |
|
H
|
Helix Biopharma Corp
OTC:HBPCF
|
CA |
Wall St Price Targets
53L Price Targets Summary
Transcontinental Inc
According to Wall Street analysts, the average 1-year price target for 53L is 4.11 EUR with a low forecast of 3.48 EUR and a high forecast of 4.83 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 53L's stock price target?
Price Target
4.11
EUR
According to Wall Street analysts, the average 1-year price target for 53L is 4.11 EUR with a low forecast of 3.48 EUR and a high forecast of 4.83 EUR.
What is the Revenue forecast for Transcontinental Inc?
Projected CAGR
-25%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is -25%.
What is the Operating Income forecast for Transcontinental Inc?
Projected CAGR
-17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is -17%.
What is the Pre-Tax Income forecast for Transcontinental Inc?
Projected CAGR
-16%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -16%.
What is the Net Income forecast for Transcontinental Inc?
Projected CAGR
-17%
The compound annual growth rate for Net Income over the next 3 years is -17%.
